Senior insider sale
SVP, Chief Accounting Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$124.3K
3.13K shares
What this filing means
HUIZENGA THEODORE ALAN plans to sell 3.13K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $124.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/7/2023ACC: 0001950047-23-003831
Officer· SVP, Chief Accounting Officer
Since Mar 2026
3.13K
Shares to sell
$124.3K
Approx. market value
2.16K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Stock Option Exercise
Cash
9/7/2023
2KRestricted Stock
Not Applicable
9/1/2023
163.00Total acquired2.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/7/2023 | Stock Option Exercise Cash | 2K | — |
9/1/2023 | Restricted Stock Not Applicable | 163.00 | — |
| Total | 2.16K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
87.00
Market value
$3.3K
9/6/2023
—Completed
Units to sell
883.00
Market value
$32.7K
9/1/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.16K
Market value
$88.2K
9/7/2023
Total
Units
3.13K
Value
$124.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/6/2023 | 87.00 | $3.3K | — | Completed |
9/1/2023 | 883.00 | $32.7K | — | Completed |
| Planned — Approximate Date | ||||
9/7/2023 | 2.16K | $88.2K | NASDAQ | Planned |
| Total | 3.13K | $124.3K | ||